GlassScriptPhysician profile
Meredith Lynn Herring
NPI 1568863256
$2,349.98
in general payments reported to CMS, 2019-2025
21 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.78 · 2022: $97.36 · 2023: $190 · 2024: $1,814 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248 · Travel and Lodging: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,248.35 |
| Travel and Lodging | $973.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,448.21 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $227.56 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $100.51 | 2021-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Abbvie INC. | $100.50 | 2023-2025 | |
| Teleflex LLC | $65.79 | 2024-2025 | Urolift, Barrigel |
| Merck Sharp & Dohme LLC | $44.11 | 2023-2024 | Lynparza, Welireg, Keytruda |
| Kowa Pharmaceuticals America, INC. | $41.00 | 2022-2023 | Seglentis |
| Myriad Genetic Laboratories, INC. | $39.26 | 2022-2025 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $34.61 | 2023-2024 | Lynparza |
| Janssen Biotech, INC. | $33.01 | 2024 | Akeega, Erleada |
| Laborie Medical Technologies Corp. | $28.15 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Immunitybio, INC. | $27.21 | 2024 | |
| Convatec INC. | $24.12 | 2022 | |
| Endo USA, INC. | $23.81 | 2024 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $22.48 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $16.67 | 2022 | |
| Astellas Pharma US INC | $16.06 | 2023 | Myrbetriq |
| Pfizer INC. | $15.95 | 2024 | |
| Urovant Sciences INC | $14.73 | 2022 | |
| Procept Biorobotics Corporation | $13.39 | 2023 | Aquabeam Robotic System |
| Foundation Medicine, INC. | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Herring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.